Page last updated: 2024-12-11

octa-2,4,6-trienoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

octatrienoic acid : Any medium-chain fatty acid with eighteen carbons and three double bonds. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5368831
CHEMBL ID1208330
SCHEMBL ID330199
SCHEMBL ID330198
MeSH IDM0172245

Synonyms (21)

Synonym
CHEMBL1208330
5205-32-3
2,4,6-octatrienoic acid
octa-2,4,6-trienoic acid
AKOS006374333
(2e,4e,6e)-octa-2,4,6-trienoic acid
nsc 16188
2,4,6-octatrienoic acid, (2e,4e,6e)-
octatrienoic acid
unii-702xzo95x4
97329-94-7
702xzo95x4 ,
(e,e,e)-2,4,6-octatrienoic acid
2,4,6-octatrienoic acid, (e,e,e)-
octatrienoic acid [inci]
SCHEMBL330199
SCHEMBL330198
IAAPVNQZSBLWKH-ICDJNDDTSA-N
(2e,4e,6e)-2,4,6-octatrienoic acid #
DTXSID20242869
Q27265816
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.69)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's6 (46.15)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.29 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.07 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (15.38%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (84.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]